UCAAMP hosts lunch focused on innovation
Join UCAAMP for lunch and an innovation panel featuring faculty from the College of Engineering and Applied Science
Event Information (passed)
Join UCAAMP for lunch and an innovation panel featuring faculty from the University of Cincinnati College of Engineering and Applied Science. The panel will include topics on UC innovations in the area of Intelligent Robotics, UAV (unmanned aerial vehicle) research, additive manufacturing, and AI (artificial intelligence) developments. Each presenter will include a brief presentation of their work followed by questions.
Panel Participants:
- Dr. Teri Reed, Executive Director of CEAS
- Dr. Ashley E. Paz y Puente, additive manufacturing
- Dr. Rashmi Jha, neuromorphic “Systems on a Chip” for artificial intelligence and cybersecurity
- Dr. Kelly Cohen, artificial intelligence
- Dr. Marc Cahay, micro- and nano- scale artificial neural networks
- Dr. Manish Kumar, unmanned aerial vehicles
- Dr. Ou Ma, intelligent robotics
Menu:
- Chicken or beef taco salad with assorted toppings
- Mexican rice
- Refried beans
- Cinnamon churros
Tags
Related Stories
Is uACR the key to cardiovascular and kidney disease prevention?
March 8, 2026
As a precision biomarker, the urinary albumin-to-creatinine ratio (uACR) can guide physicians toward personalized, patient-centered prevention and treatment of both cardiovascular disease (CVD) and chronic kidney disease (CKD), according to new data published in the Journal of Internal Medicine.
Driven by her own pain
March 8, 2026
Endometriosis is a painful and often debilitating disease that affects an estimated 6.5 million women in the U.S. It occurs when tissue similar to the lining of the uterus grows outside of it, causing pain, inflammation and sometimes infertility. Now a University of Cincinnati College of Medicine researcher is developing what is believed to be the first at-home diagnostic test.
Can you grow new brain cells?
March 6, 2026
As National Geographic recently reported, a pair of new studies have provided fresh evidence in the long-running scientific debate on if adults can grow new brain cells. The result could be game-changing for treating diseases such as Alzheimer’s and dementia.